It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
-
The Role of Scientific Advisers in the English Patents Court
-
Trying to Make Sense of the Oracle of G 2/21: T 116/18 vs. T 681/21
-
Patent case: NanoString Technologies vs. 10x Genomics and President and Fellows of Harvard College, UPC
-
Patent case: Judgment no. 141/2023 dated 5 December 2023, Spain
Random Articles:
-
A Critical Analysis of the EC Proposal for SEP Regulation
-
MPEG-2-Videosignalcodierung, Federal Patent Court (Bundesgerichtshof), 21 August 2012
-
A (not so) Wii decision from the English High Court
-
U.S. Courts Look At Method Of Use Patents In Generic Drug/ANDA Litigation
-
To suspend or not to suspend – Bundesgerichtshof on bifurcation
-
Olanzapin, District Court The Hague (Rechtbank Den Haag), 24 March 2010
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Pre-action Disclosure: Transparency is a virtue
-
I Medinol Ltd v. Abbott Ireland and Abbot Vascular International BCBA & Others, High Court, Commercial List Dublin (High Court, Commercial List Dublin), 10 March 2011
-
The EU Patent Package – Where does Europe stand End of June 2014?